Literature DB >> 19893041

Gene expression profiling of pulmonary fibrosis identifies Twist1 as an antiapoptotic molecular "rectifier" of growth factor signaling.

Robert S Bridges1, Daniel Kass, Katrina Loh, Carlota Glackin, Alain C Borczuk, Steven Greenberg.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive and typically fatal lung disease. To gain insight into IPF pathogenesis, we performed gene expression profiling of IPF lungs. Twist1, a basic helix-loop-helix protein, was found among the most consistently and highly up-regulated genes and was expressed in nuclei of type II epithelial cells, macrophages, and fibroblasts in IPF lungs. We studied the function of Twist1 in fibroblasts further, because they are the major effector cells in this disease and persist despite an ambient proapoptotic environment. Twist1 was induced by the profibrotic growth factors (GFs) basic fibroblast growth factor, platelet-derived growth factor, and epidermal growth factor in primary rat lung fibroblasts (RLFs). Suppression of Twist1 expression resulted in decreased RLF accumulation due to increased apoptosis, whereas Twist1 overexpression protected RLFs against several apoptotic stimuli. Addition of platelet-derived growth factor in combination with other GFs led to an increase in proliferation. When Twist1 was depleted, GFs continued to act as mitogens but caused a marked increase in cell death. The increase in apoptosis under basal or growth factor-stimulated conditions was partly mediated by up-regulation of the proapoptotic Bcl-2 family members, Bim and PUMA. These findings indicate that Twist1 promotes survival and accumulation of fibroblasts by shaping their responsiveness to growth factor stimulation. We propose that Twist1 represents one of the factors that promotes pathogenic accumulation of fibroblasts in fibrotic lung disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19893041      PMCID: PMC2789617          DOI: 10.2353/ajpath.2009.080954

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

1.  Mutually exclusive subsets of BH3-only proteins are activated by the p53 and c-Jun N-terminal kinase/c-Jun signaling pathways during cortical neuron apoptosis induced by arsenite.

Authors:  Hon Kit Wong; Michael Fricker; Andreas Wyttenbach; Andreas Villunger; Ewa M Michalak; Andreas Strasser; Aviva M Tolkovsky
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

2.  Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein.

Authors:  Jingyung Hur; Daphne W Bell; Kathleen L Dean; Kathryn R Coser; Pablo C Hilario; Ross A Okimoto; Erica M Tobey; Shannon L Smith; Kurt J Isselbacher; Toshi Shioda
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

3.  Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target.

Authors:  Wai Kei Kwok; Ming-Tat Ling; Tak-Wing Lee; Tracy C M Lau; Chun Zhou; Xiaomeng Zhang; Chee Wai Chua; Kwok W Chan; Franky L Chan; Carlotta Glackin; Yong-Chuan Wong; Xianghong Wang
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

4.  Gene expression profiling of familial and sporadic interstitial pneumonia.

Authors:  Ivana V Yang; Lauranell H Burch; Mark P Steele; Jordan D Savov; John W Hollingsworth; Erin McElvania-Tekippe; Katherine G Berman; Marcy C Speer; Thomas A Sporn; Kevin K Brown; Marvin I Schwarz; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2006-09-22       Impact factor: 21.405

5.  Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix.

Authors:  Kevin K Kim; Matthias C Kugler; Paul J Wolters; Liliane Robillard; Michael G Galvez; Alexis N Brumwell; Dean Sheppard; Harold A Chapman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-21       Impact factor: 11.205

6.  Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis.

Authors:  Brigham C Willis; Janice M Liebler; Katherine Luby-Phelps; Andrew G Nicholson; Edward D Crandall; Roland M du Bois; Zea Borok
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

7.  Gefitinib prevents bleomycin-induced lung fibrosis in mice.

Authors:  Yoshiki Ishii; Sakae Fujimoto; Takeshi Fukuda
Journal:  Am J Respir Crit Care Med       Date:  2006-06-01       Impact factor: 21.405

8.  Twist is a potential oncogene that inhibits apoptosis.

Authors:  R Maestro; A P Dei Tos; Y Hamamori; S Krasnokutsky; V Sartorelli; L Kedes; C Doglioni; D H Beach; G J Hannon
Journal:  Genes Dev       Date:  1999-09-01       Impact factor: 11.361

9.  Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung.

Authors:  B D Uhal; I Joshi; W F Hughes; C Ramos; A Pardo; M Selman
Journal:  Am J Physiol       Date:  1998-12

10.  Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis.

Authors:  Annie Pardo; Kevin Gibson; José Cisneros; Thomas J Richards; Yinke Yang; Carina Becerril; Samueal Yousem; Iliana Herrera; Victor Ruiz; Moisés Selman; Naftali Kaminski
Journal:  PLoS Med       Date:  2005-09-06       Impact factor: 11.069

View more
  34 in total

1.  Overexpression of inhibitor of DNA-binding 2 attenuates pulmonary fibrosis through regulation of c-Abl and Twist.

Authors:  Jibing Yang; Miranda Velikoff; Manisha Agarwal; Supparerk Disayabutr; Paul J Wolters; Kevin K Kim
Journal:  Am J Pathol       Date:  2015-02-03       Impact factor: 4.307

Review 2.  Aging and Lung Disease. Clinical Impact and Cellular and Molecular Pathways.

Authors:  Mauricio Rojas; Ana L Mora; Maria Kapetanaki; Nathaniel Weathington; Mark Gladwin; Oliver Eickelberg
Journal:  Ann Am Thorac Soc       Date:  2015-12

3.  Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury.

Authors:  Daniel J Kass; Guoying Yu; Katrina S Loh; Asaf Savir; Alain Borczuk; Rehan Kahloon; Brenda Juan-Guardela; Giuseppe Deiuliis; John Tedrow; Jiin Choi; Thomas Richards; Naftali Kaminski; Steven M Greenberg
Journal:  Am J Pathol       Date:  2012-03-16       Impact factor: 4.307

4.  p53-Pirh2 Complex Promotes Twist1 Degradation and Inhibits EMT.

Authors:  Yang Yang-Hartwich; Roslyn Tedja; Cai M Roberts; Jamie Goodner-Bingham; Carlos Cardenas; Marta Gurea; Natalia J Sumi; Ayesha B Alvero; Carlotta A Glackin; Gil Mor
Journal:  Mol Cancer Res       Date:  2018-08-21       Impact factor: 5.852

Review 5.  Myofibroblast differentiation and survival in fibrotic disease.

Authors:  Kornelia Kis; Xiaoqiu Liu; James S Hagood
Journal:  Expert Rev Mol Med       Date:  2011-08-23       Impact factor: 5.600

6.  Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension.

Authors:  Eileen Hsu; Haiwen Shi; Rick M Jordan; James Lyons-Weiler; Joseph M Pilewski; Carol A Feghali-Bostwick
Journal:  Arthritis Rheum       Date:  2011-03

7.  MicroRNA-144-3p targets relaxin/insulin-like family peptide receptor 1 (RXFP1) expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis.

Authors:  Harinath Bahudhanapati; Jiangning Tan; Justin A Dutta; Stephen B Strock; John Sembrat; Diana Àlvarez; Mauricio Rojas; Benedikt Jäger; Antje Prasse; Yingze Zhang; Daniel J Kass
Journal:  J Biol Chem       Date:  2019-02-01       Impact factor: 5.157

8.  TWIST1 promotes invasion through mesenchymal change in human glioblastoma.

Authors:  Svetlana A Mikheeva; Andrei M Mikheev; Audrey Petit; Richard Beyer; Robert G Oxford; Leila Khorasani; John-Patrick Maxwell; Carlotta A Glackin; Hiroaki Wakimoto; Inés González-Herrero; Isidro Sánchez-García; John R Silber; Philip J Horner; Robert C Rostomily
Journal:  Mol Cancer       Date:  2010-07-20       Impact factor: 27.401

9.  Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.

Authors:  Rute B Marques; Natasja F Dits; Sigrun Erkens-Schulze; Wytske M van Weerden; Guido Jenster
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

Review 10.  Personalized medicine: applying 'omics' to lung fibrosis.

Authors:  Jose D Herazo-Maya; Naftali Kaminski
Journal:  Biomark Med       Date:  2012-08       Impact factor: 2.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.